Thank you for registering your account
Thanks for joining touchIMMUNOLOGY to hear about news and updates from across the Immunology community.
We’ve sent you an email to verify your email address. Please click on the link to confirm your account.
You can review your email preferences at any time or update your account details
Eosinophilic inflammatory diseases of the respiratory system: New therapeutic options
Watch a panel of experts discuss how to identify and manage patients with inflammatory respiratory diseases, with a focus on severe eosinophilic asthma.
- Recognize the role of eosinophils and type 2 inflammation in respiratory disease
- Understand the diagnostic methods used to differentiate inflammatory diseases of the respiratory system
- Recall disease states that may benefit from therapies that target the complex interaction between eosinophils and their environment
Women with axSpA: Navigating the childbearing years
Join Prof. Peter C Taylor as he discusses the unique challenges that women with axSpA face on their journey to motherhood.
- Recognize that prevalence, diagnosis, disease progression and treatment efficacy differ between men and women with axSpA
- Evaluate the unique challenges that exist for women of childbearing age with axSpA
- Discuss optimal treatment strategies for women of childbearing age with axSpA
Kim Papp, AAD VMX 2021: Secukinumab PURE Study
We were delighted to discuss with Dr Kim Papp (Probity Medical Research, Waterloo, ON, Canada) results from the PURE study (NCT02786186), designed to investigate the long-term safety profile of secukinumab in patients with moderate to severe chronic plaque psoriasis. The abstract ‘Secukinumab helps achieving clear/almost clear skin and improve quality of life in psoriasis over […]
Amy S. Paller, AAD VMX: Advances in the Treatment of Atopic Dermatitis in Children
Following the AAD VMX meeting we caught up with Prof. Amy S. Paller (Northwestern University Feinberg School of Medicine, Chicago, IL, USA) to discuss some of the presentations and recent advances being made in the treatment of children with atopic dermatitis. Disclosures: Prof. Amy Paller has acted as a consultant with honorarium for AbbVie, Abeona, […]
Leon Kircik, AAD VMX 2021: Roflumilast Foam in Scalp and Body Psoriasis
Prof. Leon Kircik (Icahn School of Medicine at Mount Sinai, New York, NY, USA) kindly took the time to speak with us about the results from the recent phase 2b study investigating roflumilast foam in the treatment of scalp and body psoriasis. His abstract entitled ‘Once-daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: A […]
Xavier Mariette, EULAR 2021: Belimumab plus Rituximab in Primary Sjögren’s Syndrome
It was a delight to catch up with Professor Xavier Mariette (Université Paris-Saclay and Hôpital Bicêtre, Paris, France) around the phase 2 study investigating subcutaneous belimumab and intravenous rituximab in primary Sjögren’s syndrome. The abstract ‘SAFETY AND EFFICACY OF SUBCUTANEOUS BELIMUMAB AND INTRAVENOUS RITUXIMAB COMBINATION IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME: A PHASE 2, RANDOMISED, PLACEBO-CONTROLLED […]
Letter from the Editor-in-Chief
touchREVIEWS in RMD. 2021;1:Online ahead of journal publication
Dear readers I am delighted to take on the mantle of Editor-in-Chief for touchREVIEWS in RMD and am grateful to have this opportunity to share some details of my background and my passion for great medical education with you. My first job after leaving school was to work (very briefly) for an estate agent in […]